Literature DB >> 24811088

The efficacy of semirigid hip orthosis in the delayed treatment of developmental dysplasia of the hip.

Ismail Uraş1, Osman Yüksel Yavuz, Murat Uygun, Hamdullah Yldrm, Mahmut Kömürcü.   

Abstract

UNLABELLED: This study assessed the use of semirigid hip orthosis to stabilize the femoral head into the acetabulum in the delayed treatment of developmental dysplasia of the hip (DDH; Graf type IIb or more severe) under the age of 6 months. Ninety-eight hips from 75 patients (four boys, 71 girls) were evaluated retrospectively. The mean age at treatment initiation was 3.2±1.3 months (1-6 months). As the dysplastic hip matured into a type I hip, we applied the weaning regimen for 1 month. Seventy-two patients (96%) were treated successfully in 4.2±1.1 months (2-8 months). All of the failures were type IV hips. We did not detect any acetabular or femoral head pathology in the later follow-up. Semirigid hip orthosis is safe and effective as the first-line treatment method for delayed DDH except in type IV hips in patients under 6 months of age. LEVEL OF EVIDENCE: Level IV. Case series.

Entities:  

Mesh:

Year:  2014        PMID: 24811088     DOI: 10.1097/BPB.0000000000000052

Source DB:  PubMed          Journal:  J Pediatr Orthop B        ISSN: 1060-152X            Impact factor:   1.041


  2 in total

1.  Tübingen hip flexion splint for the treatment of developmental dysplasia of the hip in children younger than six months age: a meta-analysis.

Authors:  Xinwang Zhi; Xietian Xiao; Yuwei Wan; Ping Wei; Federico Canavese; Hongwen Xu
Journal:  J Child Orthop       Date:  2021-08-20       Impact factor: 1.548

2.  Reduction of the dislocated hips with the Tübingen hip flexion splint in infants.

Authors:  Murat Yegen; Hakan Atalar; Cuneyd Gunay; Osman Yuksel Yavuz; Ismail Uras; Ahmet Yigit Kaptan
Journal:  Int Orthop       Date:  2018-11-27       Impact factor: 3.075

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.